Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-12-30

Clinical Trial Update: The RE-ENERGIZE Study: RandomizEd Trial of ENtERal Glutamine to minimIZE Thermal Injury [Phase 3]

View source ↗

Summary

Phase 3 randomized trial investigating enteral glutamine to minimize thermal injury in burns patients; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Enteral Glutamine (glutamine)

Snippet

Sponsor: Daren K. Heyland | Conditions: Burns | Phase 3 | Status: UNKNOWN